Theradiag: takeover bid reopened on January 18
Following the tender offer, Biosynex holds 9,032.820 shares representing the same number of voting rights, i.e. 68.86% of the share capital and at least 68.56% of the voting rights of this company.
The offeror irrevocably undertakes to acquire all the shares issued or likely to be issued prior to the close of the reopened offer at a unit price of 2.30 euros. It will also acquire shares on the market until the close of the reopened offer.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction